Improved neurodevelopmental outcomes for extremely low birth weight infants in 2000-2002

Pediatrics

Volumn 119, Issue 1, 2007, Pages 37-45

  Wilson Costello, Deanne ^a,b   Friedman, Harriet ^a   Minich, Nori ^a   Siner, Bonnie ^a   Taylor, Gerry ^a   Schluchter, Mark ^a   Hack, Maureen ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Cerebral palsy; Extremely preterm infants; Neurologic handicap

Indexed keywords

ARTICLE; BRAIN HEMORRHAGE; CEREBRAL PALSY; CHILD CARE; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DELIVERY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NEWBORN CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; OUTCOME ASSESSMENT; PERINATAL CARE; PRIORITY JOURNAL; SEPSIS; STEROID THERAPY; SURVIVAL; VERY LOW BIRTH WEIGHT; DEVELOPMENTAL DISORDER; EXTREMELY LOW BIRTH WEIGHT; INFANT MORTALITY; NEUROLOGIC DISEASE; NEWBORN; PREMATURITY;

CEREBRAL PALSY; DEVELOPMENTAL DISABILITIES; HUMANS; INFANT MORTALITY; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; NERVOUS SYSTEM DISEASES;

EID: 33846900046     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2006-1416     Document Type: Article

References (59)

1. Fanaroff AA, Hack M, Walsh MC. The NICHD Neonatal Research Network: changes in practice and outcomes during the first 15 years. Semin Perinatol. 2003;27:281-287
2. Doyle LW, for The Victorian Infant Collaborative Study Group. Improved outcome into the 1990s for infants weighing 500-999 g at birth. Arch Dis Child Fetal Neonatal Ed. 1997;77:F91-F94
3. Robertson C, Hrynchyshyn GJ, Etches PC, Pain KS. Population-based study of the incidence, complexity and severity of neurologic disability among survivors weighing 500 through 1250 grams at birth: a comparison of two birth cohorts. Pediatrics. 1992;90:750-755
4. Lorenz JM, Wookiever DE, Jetton JR, Paneth N. A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med. 1998;152:425-435
5. Emsley HCA, Wardle SP, Sims DG, Chiswick ML, D'Souza SWD. Increased survival and deteriorating developmental outcome in 23-25 week old gestation infants, 1990-1994 compared with 1984-1989. Arch Dis Child Fetal Neonatal Ed. 1998;78:F99-F104
6. Hack M, Friedman H, Fanaroff AA. Outcome of extremely low birth weight infants. Pediatrics. 1996;98:931-937
7. Hack M, Taylor HG, Drotar D, et al. Chronic conditions, functional limitations, and special health care needs of school-age children born extremely low birth weight in the 1990s. JAMA. 2005;294:1-9
8. Marlow N, Wolke D, Bracewell MA, Samara M, for the EPI-Cure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005;352:9-19
9. Stark AE, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 2001;344:95-101
10. American Academy of Pediatrics, Committee on Fetus and Newborn; Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109:330-338
11. Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MD. Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics. 2003;111(4). Available at: www.pediatrics.org/cgi/content/ full/111/4/SE1/e519
12. Wilson-Costello D, Friedman H, Minich N, Fanaroff A, Hack M. Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s. Pediatrics. 2005;115:997-1003
13. National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Statement. 1994;12:1-24
14. Fanaroff AA, Martin RJ, eds. Neonatal-Perinatal Medicine. 7th ed. Philadelphia, PA: WB Saunders; 2001
15. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 5th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2002
16. Shennan AT, Dunn MJ, Ohlsson A, Lenox K. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82:527-532
17. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg. 1978;187:1-7
18. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhages; a study of infants with birthweights less than 1500 grams. J Pediatr. 1978;92:529-534
19. Bayley N. Bayley Scales of Infant Development. New York, NY: Psychological Corp; 1969
20. Bayley N. Bayley Scales of Infant Development. 2nd ed. San Antonio, TX: Psychological Corp; 1993
21. Amiel-Tison C, Stewart AL. Follow-up studies in the first five years of life: a pervasive assessment of neurologic function. Arch Dis Child. 1989;64:496-502
22. Bax M. Terminology and classification of cerebral palsy. Dev Med Child Neurol. 1964;6:295-297
23. World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th rev. Geneva, Switzerland: World Health Organization; 1992
24. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2). Available at: www.pediatrics.org/cgi/content/full/108/2/e35
25. Yeh TF, Lin YJ, Lin HC, et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med. 2004;350:1304-1313
26. Baud O. Postnatal steroid treatment and brain development. Arch Dis Child. 2004;89:96-100
27. Short EJ, Klein NK, Lewis BA, et al. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics. 2003;112(5). Available at: www.pediatrics.org/cgi/content/ full/112/5/e359
28. Barrington KJ. The adverse neurodevelopmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr. 2001;1:1
29. Vohr BR, Wright LL, Dusick AM, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics. 2000;105:1216-1226
30. Hintz SR, Kendrick DE, Vohr BR, et al. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics. 2005;115:1645-1651
31. Vohr BR, Wright LL, Poole K, et al. Neurodevelopmental outcomes of extremely low birth weight infants less than 32 weeks' gestation between 1993 and 1998. Pediatrics. 2005;116:635-643
32. Doyle LW, Anderson PJ; Victorian Infant Collaborative Study Group. Improved neurosensory outcome at 8 years of age of extremely low birth weight children born in Victoria over 3 different eras. Arch Dis Child Fetal Neonatal Ed. 2005;90:F484-F485
33. Nosarti C, Al-Asady MHS, Frangou S, Stewart AL, Rifkin L, Marray RM. Adolescents who were born very preterm have decreased brain volumes. Brain. 2002;125:1616-1623
34. Abernethy LJ, Cooke RW, Foulder-Hughes L. Caudate and hippocampal volumes, intelligence, and motor impairment in 7-year-old children who were born preterm. Pediatr Res. 2004;55:884-893
35. Lodygensky GA, Rademaker K, Zimine S, et al. Structural and functional brain development after hydrocortisone treatment for neonatal chronic lung disease. Pediatrics. 2005;116:1-7
36. Hassan AH, von Rosenstiel P, Patchev VK, Holsboer F, Almeida OF. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp Neurol. 1996;140:43-52
37. Wu YW, Colford JM. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis. JAMA. 2000;284:1417-1424
38. Wilson-Costello D, Borawski E, Friedman H, Redline R, Fanaroff A, Hack M. Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics. 1998;102:315-322
39. Grether, JK, Nelson KB, Emery ES, III, Cummins SK. Prenatal and perinatal factors and cerebral palsy in very low birth weight infants. J Pediatr. 1996;128:407-414
40. Murphy DJ, Sellers S, MacKenzie IZ, Yudkin PL, Johnson AM. Case control study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies. Lancet. 1995;346:1449-1454
41. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA. 2004;292:2357-2365
42. Dammann O, Leviton A. Maternal intrauterine infection, cytokines and brain damage in the preterm newborn. Pediatr Res. 1997;42:1-8
43. Yoon BH, Jun JK, Romero R, et al. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1B, and tumor necrosis factor-a), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 1997;177:19-26
44. Aly H, Herson V, Duncan A, et al. Is bloodstream infection preventable among premature infants? A tale of two cities. Pediatrics. 2005;115:1513-1518
45. Kumar P. Effect of decreased use of postnatal corticosteroids on morbidity in extremely low birthweight infants. Am J Perinatol. 2005;22:77-81
46. Kaempf JW, Campbell B, Sklar RS, et al. Implementing potentially better practices to improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501 and 1250 grams. Pediatrics. 2003;111(4 pt 2). Available at: www.pediatrics.org/cgi/content/full/111/4/SE1/e534
47. Nelson KB, Ellenberg JH. Children who "outgrew" cerebral palsy. Pediatrics. 1982;69:529-536
48. Ment LR, Vohr B, Allen W, et al. Change in cognitive function over time in very low-birth-weight infants. JAMA. 2003;289:705-711
49. Hack M, Taylor HG, Drotar D, et al. Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of extremely low birth-weight children at school age. Pediatrics. 2005;116:333-341
50. Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics. 2002;110:143-151
51. Berlin LJ, Brooks-Gunn J, McCarton C, McCormick MC. The effectiveness of early intervention: existing risk factors and pathways to enhanced development. Prev Med. 1998;27:238-245
52. Blauw-Hosper CH, Hadders-Algram. A systematic review of the effects of early intervention on motor development. Dev Med Child Neurol. 2005;47:421-432
53. Johnson S, Ring W, Anderson P, Marlow N. Randomized trial of parental support for families with very preterm children: outcome at 5 years. Arch Dis Child. 2005;90:909-915
54. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med. 2003;349:2099-2107
55. Mestan KKL, Marks JD, Hecox K, Huo D, Schreiber MD. Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N Engl J Med. 2005;353:23-32
56. Field D, Elbourne D, Truesdale A, et al. Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial. Pediatrics. 2005;115:926-936
57. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med. 2005;353:13-22
58. Silverman WA. Personal reflections on lessons learned from randomized trials involving newborn infants from 1951 to 1967. Clin Trials. 2004;1:179-184
59. Goldenberg RL, Jobe AH. Prospects for research in reproductive health and birth outcomes. JAMA. 2001;285:633-639